Blockchain

Aleph Zero Launches NEON Program, Enlists Major Global Partners Including Pairpoint, Backed by Vodafone and Sumitomo

on

    More in Blockchain:

    Zug, Switzerland, September 10th, 2024, Chainwire

    The Next-Gen Enterprise and Opportunity Navigator (NEON) program will support global enterprises on their journey into web3, fostering innovation and widespread adoption of blockchain technology.

    The Aleph Zero Foundation, a pioneer in privacy-enhancing blockchain infrastructure, announces the launch of its NEON Program, a comprehensive initiative designed to support enterprises from various sectors in harnessing the power of blockchain technology. The program will deliver dedicated resources, expert guidance, and ease of access to innovative technology to facilitate deeper integration of privacy-enhancing blockchain technology across various business use-cases.

    The NEON Program goes beyond traditional enterprise support by offering a comprehensive suite of resources tailored to each member’s unique needs and ambitions in the web3 space. At its core, the program provides a team of dedicated business and technical experts who work closely with members to navigate the complexities of web3 integration. 

    The program caters to a wide range of companies, from those taking their first steps into web3 to seasoned players. This hands-on approach is complemented by a wealth of educational resources, in-depth workshops, and tailored support designed to keep members at the forefront of market and tech developments. By fostering connections with industry experts and exploring potential new revenue streams through ecosystem participation, the NEON Program empowers enterprises to not just adapt to the evolving digital landscape, but to actively shape it.

    “Blockchain technology is rapidly expanding into diverse industries, powering an ever-growing array of use cases,” said Antoni Zolciak, Co-founder of Aleph Zero. “As this landscape evolves, businesses need expert guidance to navigate and harness this technology effectively. We’re incredibly proud to launch the NEON Program, offering tailored support that empowers enterprises at all stages of blockchain adoption. Our goal is to foster innovation, drive adoption, and help businesses unlock the full potential of web3 in their operations.”

    Strategic Partnerships Across Industries

    Aleph Zero has already secured partnerships with global leaders in the telecommunications sector, including Deutsche Telekom and stc Bahrain, demonstrating the blockchain’s capability to meet the rigorous demands of large-scale operations. The program is expanding to include companies and organizations from various industries:

    • Pairpoint (A Vodafone and Sumitomo Company): Born from two leading multinationals, Vodafone and Sumitomo, Pairpoint enables devices to act as autonomous ‘economic agents’, allowing them to transact directly between them to create better user experiences. For example, electric cars can pay for their energy, delivery trucks can sell spare capacity, or smart meters can sell their solar production to their neighbors.
    • CAMARA Foundation (Linux Foundation): Launched in 2021 under the Linux Foundation and GSMA, the CAMARA Project aims to standardize APIs for telecommunications networks. Aleph Zero joined as the first blockchain General Member to develop and contribute to blockchain-specific initiatives. A key focus of this collaboration is the Blockchain Public Address API, which could revolutionize how users interact with blockchain technologies on mobile devices.

    “At Pairpoint, we’re exploring privacy-focused technologies in the evolving ‘Economy of Things,’ where devices are becoming smarter and more autonomous,” said Siva Balasuriyar, CFO and Web3 Lead at Pairpoint. “Joining the NEON program provides Pairpoint with the resources and partnerships we need to strengthen our own knowledge, whilst collaborating with Aleph Zero and others in navigating this groundbreaking landscape. Supported by this partnership, Pairpoint will deploy and operate validator nodes to enhance the resilience and security of the blockchain infrastructure.”

    Introducing the Next-Gen Enterprise & Opportunity Navigator Program

    The launch of the Next-Gen Enterprise & Opportunity Navigator (NEON) Program marks a new phase in Aleph Zero’s engagement with enterprises. NEON is designed to help members effectively navigate the ecosystem, providing crucial support and fostering collaboration. With Aleph Zero’s unique technology stack that features advanced zero-knowledge privacy capabilities, the program is particularly appealing for applications requiring stringent data privacy.

    Membership Benefits of the NEON Program:

    • Dedicated Account Manager: Each member is assigned a Single Point of Contact (SPOC) for personalized business and technical support.
    • Regular Insights: Members gain access to the latest ecosystem insights through regular updates from the NEON Program.
    • Exclusive Networking Opportunities: Members can participate in exclusive networking opportunities at key web3 conferences, events, hackathons, and ecosystem dinners.
    • Exploratory Workshops: Members have the opportunity to engage in workshops designed to explore opportunities within Web3 and the Aleph Zero platform.
    • Custom AZERO Addresses: Each member receives a unique “yourcompany.azero” enterprise blockchain address.
    • Access to Focus Groups: Members can join specialized focus groups on “Data & Tooling,” “Loyalty, Art & Collectibles,” and “Web3 Education,” each tailored to provide in-depth exploration of specific areas of interest.

    For more information on how to join the Aleph Zero NEON Program and benefit from its offerings, please visit the official website.

    About Aleph Zero

    Aleph Zero is a privacy-first ecosystem of blockchain solutions that are engineered for speed, data confidentiality, and ease of development. It achieves efficiencies akin to conventional web2 systems, upholds rigorous standards for data protection via zero-knowledge, and offers a comprehensive toolset for development across web3 that ranges from WASM-based Rust to EVM-based Solidity environments. Aleph Zero’s versatility is highlighted by over 40 use cases being actively developed, showcasing its adaptability across various sectors and applications. These use cases are part of an engaged community and growing ecosystem of web3 applications that are supported by Aleph Zero ecosystem development programs.

    For more information, readers can visit https://alephzero.org/ 

    About Pairpoint

    Pairpoint is creating the world’s largest Economy of Things (EoT) Ecosystem by providing a secure digital platform that allows vehicles, devices, and machines to autonomously and seamlessly interact and trade with each other.

    Headquartered in the UK with offices in London and Lisbon, Pairpoint is backed by a €60M investment from Vodafone Group and Sumitomo Group. For more information on Pairpoint, readers can visit https://www.pairpoint.io. 

    For any enquiries about this release, readers can please contact josh@serotonin.co 

    Contact

    PR Manager
    Josh Adams
    Aleph Zero
    josh@serotonin.co

    PostAd_coinrule_banner728x90

    Leave a Comment

    Your email address will not be published. Required fields are marked *

    *

    PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics

    2024-09-19T13:00:00Z

    Strategic partnership aims to further develop Cube’s award-winning AI guided platform for Software as a Service (SaaS) for the private sector and large healthcare systems and diagnostic to support clinicians and patients in making informed therapeutic decisions from early detection to personalized treatment and disease monitoring, for improved health outcomes

    AMSTERDAM, Sept. 19, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) PersonalAIze and RenovaroCube are proud to announce a strategic partnership to develop, validate, and commercialize Cube’s AI-driven, multi-omic platform for early detection of cancer and other diseases. This strategic partnership aims to provide services to many AI companies and healthcare systems while also creating the next generation of medical diagnostics through cutting-edge AI by driving greater accuracy, transparency, and trust in healthcare solutions.

    Prof. Mark Hoogendoorn, Co-CEO and Co-Founder PersonalAIze: "The strategic partnership between PersonalAIze and Cube has the potential to provide a transformative leap in healthcare diagnostics, uniting cutting-edge AI with trusted, high-performance capabilities and industry related in-depth expertise.”

    Frank van Asch, Founder and CTO of RenovaroCube,” Together, we are pioneering a future where healthcare outcomes are improved by training models for multiple decisions through the entire health journey, ensuring the right accuracy for therapeutic decisions in every disease stage.”

    The first phase of the collaboration focuses on establishing a strong foundation for the partnership, with PersonalAIze providing critical expertise in the integration of AI into healthcare. It will enhance existing collaborations with Academic and corporate partners and create new ones to build an eco-system to help develop and bring to the market a cutting-edge SaaS model and the next generation highly accurate diagnostics, starting with cancer.

    Prof Sandjai Buhlai, Co-CEO and Co-Founder PersonalAIze: “This collaboration signals a bold step forward in utilizing the full potential of AI potentially to help revolutionize early-stage medical interventions and diagnosis at the earliest stage of cancer before imaging has been able to detect the tumors.”

    Key contributions from PersonalAIze include:

    • Ethical AI: Ensuring the AI models are free from harmful biases and trained to support fairness and inclusivity in medical diagnostics.
    • Legal Guidance: Providing expert advice on legal responsibilities tied to AI outputs, including issues of AI accountability and potential liability.
    • Regulatory Compliance: Assisting in navigating existing and emerging regulations such as NEN, ISO, GDPR, and the AI Act, ensuring the platform adheres to all relevant healthcare regulations and clinical guidelines.
    • Medical and Diagnostic Input: Offering support in clinical validation in collaboration with medical scientists to ensure the AI is reliable and effective in real-world medical environments.
    • Explainable AI: Developing AI models that are transparent, fostering trust and confidence from both healthcare providers and patients.

    Key Resources and Support from PersonalAIze
    As part of the collaboration, PersonalAIze will contribute:

    • Expert Personnel: Including a Principal Investigator (PI) to lead clinical AI efforts, a project manager to coordinate the collaboration and a strategic advisor to oversee the scientific strategy and execution.
    • Research and Talent Capacity: Leveraging academic partnerships to ensure access to cutting-edge research and innovation and facilitating talent scouting to support the project’s development.
    • Academic Spin-Out Opportunities: Supporting the commercialization of academic research through potential spin-out ventures related to AI diagnostics.
    • Co-Development of AI Platform: Jointly developing a science-driven, evidence-based AI platform that meets rigorous clinical and regulatory standards.
    • Ongoing Research and Publications: Contributing to the body of research through support with peer-reviewed publications in collaboration with clinical experts that will help build trust within the medical community and among regulatory bodies.
    • Architecture and Strategy Guidance: Continuously advising on the platform’s architecture and strategic direction, ensuring it stays aligned with the latest industry trends and scientific advancements.
    • Trusted AI: Developing a trustworthy, explainable AI platform that inspires confidence among healthcare providers and patients through clear and transparent decision-making processes.

    About PersonalAIze
    PersonalAIze focuses on building solutions that improve healthcare by leveraging state-of-the-art AI techniques. It has been founded by four experienced professors bringing together decades of research experience in AI and healthcare with the aim to bring the latest scientific AI developments into healthcare practice faster. PersonalAIze does this through both consultancy and product development and targets clinical decision-making systems as well as improvement of health care operations such as capacity planning.

    About Renovaro
    Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.

    RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective. RenovaroCube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in disease agnostic decision support.

    Forward-Looking Statements
    Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

    For media inquiries, please contact: karen@renovarocube.com

    Source: Renovaro Inc.


    GlobeNewsWire News

    Recent Comments